Double-blind, randomized, placebo-controlled phase I study, to study the tolerability and immunogenicity of 4 RUTI antituberculous vaccine different doses (5, 25, 100 y 200microg of FCMtb) in healthy volunteers

Trial Profile

Double-blind, randomized, placebo-controlled phase I study, to study the tolerability and immunogenicity of 4 RUTI antituberculous vaccine different doses (5, 25, 100 y 200microg of FCMtb) in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 29 May 2009

At a glance

  • Drugs Tuberculosis vaccine (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions
  • Most Recent Events

    • 29 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top